Vir jumps on Gilead licensing deal worth up to $1.9B for cancer drugs
Vir jumps on Gilead licensing deal worth up to $1.9B for cancer drugs
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Vir jumps on Gilead licensing deal worth up to $1.9B for cancer drugs